Skip to main content
About us
Contact Us
Home
IPM Wound Gel Bio
IPM Wound Glyco Study Abstracts
IPM™ Wound Gel Bio Clinical Study
IPM Wound Gel Bio Dr. Mayer study
Endorsement from Dr. Mayer
IPM Wound Glyco Study Abstracts
News
Patents
News
04/24/2023
GlycoBioSciences Inc. (“Glyco”) announces an additional patent infringement law suit.
04/06/2023
law suit in Canada against Johnson and Johnson
03/16/2023
Glyco and L’Oreal US have entered a settlement agreement
01/26/2023
Andromaco to cease and desist, from any further sales or production of Hyalocare in Mexico.
06/14/2022
Glyco’s Canadian Patent 2,896,038, has been allowed
11/11/2021
Canadian Market Important Notice
04/03/2014
GlycoBioSciences Inc. Obtains FDA Clearance for 510 (k) K123193 for bio-fermented based IPM Wound Gel
